Fuchs' Endothelial Dystrophy

Cataract surgery is a highly refined procedure nowadays.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

VILAMOURA, Portugal — At a time when more patients want to minimize the use of spectacles, cataract surgery with implantation of a Vivity IOL is an option in eyes with Fuchs’ dystrophy.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Francis W. Price Jr., MD, discusses an engineered fibroblast growth factor from Trefoil Therapeutics for Fuchs’ endothelial corneal dystrophy.

MILAN — In the midst of the pandemic, three cases of endothelial dysfunction referred for PK due to severe corneal scarring were resolved with anterior lamellar keratectomy and DMEK by Lamis Baydoun, MD, PhD.

The latest issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, which uses video-based education to advance knowledge and training of ophthalmic surgeons, is now online.

In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting via Zoom, Richard L. Lindstrom, MD, discusses the first prospective trial of netarsudil for the treatment of Fuchs’ dystrophy.

Descemet’s membrane endothelial keratoplasty has changed the management of endothelial pathologies. It is now widely adopted and well managed by most surgeons, but concerns remain about long-term graft survival, according to one specialist.

KOLOA, Hawaii — At Hawaiian Eye 2020, Marian S. Macsai, MD, discusses cataract surgery in patients with Fuchs’ corneal dystrophy.

PARIS — For some patients, the use of a topical Rho kinase inhibitor following a Descemet’s stripping only procedure for Fuchs’ dystrophy “can be life-changing,” Kathryn Colby, MD, PhD, said at EuCornea 2019.